• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CK2β 和 XIAP 的过表达与胆管癌患者的预后不良相关。

Overexpressions of CK2β and XIAP are associated with poor prognosis of patients with cholangiocarcinoma.

机构信息

Department of Hepatobiliary Surgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310006, China.

出版信息

Pathol Oncol Res. 2014 Jan;20(1):73-9. doi: 10.1007/s12253-013-9660-y. Epub 2013 Jul 5.

DOI:10.1007/s12253-013-9660-y
PMID:23828693
Abstract

To investigate the expressions of casein kinase II β (CK2β) and X-Linked inhibitor of apoptosis protein (XIAP) in cholangiocarcinoma (CCA) and evaluated their correlations with major clinicopathologic features and patients' survival. Fifty CCA specimens and 20 normal liver tissues were included in the study. Immunohistochemical staining was used to determine the expression levels of CK2β, XIAP in normal and CCA tissues. The relationships of CK2β and XIAP expressions with clinicopathologic parameters and clinical outcome were evaluated. High immunostaining of CK2β and XIAP were observed in 66% (33/50) and 68% (34/50) of CCA tissues, which were significantly higher than that of normal liver tissues 0% (0/20) and 25% (5/20). The high expression of CK2β was significantly associated with TNM stage (P = 0.036), histological grade (P = 0.020) and high serum CEA level (P = 0.010), while high expression of XIAP was only associated with TNM stage (P = 0.014) and high serum CEA level (P = 0.001). By univariant analysis, patients with high expression of CK2β and XIAP demonstrate significantly poorer overall survival (P = 0.003 vs P = 0.018). Cox regression model showed that positive expression of CK2βis an independent factor of prognosis (P = 0.004). The expressions of CK2β and XIAP in CCA tissues showed strong correlations with the tumor progression, CK2β may be applied as a potential prognostic marker for CCA.

摘要

目的

研究酪蛋白激酶 IIβ(CK2β)和 X 连锁凋亡抑制蛋白(XIAP)在胆管癌(CCA)中的表达情况,并评估其与主要临床病理特征和患者生存的关系。方法:收集 50 例 CCA 标本和 20 例正常肝组织,采用免疫组织化学染色法检测 CK2β、XIAP 在正常和 CCA 组织中的表达水平,评估 CK2β、XIAP 表达与临床病理参数和临床结局的关系。结果:CCA 组织中 CK2β和 XIAP 的高免疫染色率分别为 66%(33/50)和 68%(34/50),明显高于正常肝组织的 0%(0/20)和 25%(5/20)。CK2β 的高表达与 TNM 分期(P=0.036)、组织学分级(P=0.020)和高血清 CEA 水平(P=0.010)显著相关,而 XIAP 的高表达仅与 TNM 分期(P=0.014)和高血清 CEA 水平(P=0.001)相关。单因素分析显示,CK2β 和 XIAP 高表达患者的总生存率明显较低(P=0.003 与 P=0.018)。Cox 回归模型显示,CK2β 阳性表达是预后的独立因素(P=0.004)。CCA 组织中 CK2β 和 XIAP 的表达与肿瘤进展密切相关,CK2β 可能成为 CCA 的潜在预后标志物。

相似文献

1
Overexpressions of CK2β and XIAP are associated with poor prognosis of patients with cholangiocarcinoma.CK2β 和 XIAP 的过表达与胆管癌患者的预后不良相关。
Pathol Oncol Res. 2014 Jan;20(1):73-9. doi: 10.1007/s12253-013-9660-y. Epub 2013 Jul 5.
2
[Expression of pGSK-3α/β Tyr279/216 and XIAP proteins in cholangiocarcinoma and their clinical significance].[胆管癌中pGSK-3α/β Tyr279/216和XIAP蛋白的表达及其临床意义]
Zhonghua Zhong Liu Za Zhi. 2013 May;35(5):366-71. doi: 10.3760/cma.j.issn.0253-3766.2013.05.010.
3
miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.miR-378 可作为胆管癌的预后生物标志物,促进肿瘤增殖、迁移和侵袭。
Cancer Biomark. 2019;24(2):173-181. doi: 10.3233/CBM-181980.
4
Overexpression of nuclear protein kinase CK2 Beta subunit and prognosis in human gastric carcinoma.核蛋白激酶 CK2β亚单位在人胃癌中的过表达及其预后意义。
Ann Surg Oncol. 2010 Jun;17(6):1695-702. doi: 10.1245/s10434-010-0911-9. Epub 2010 Jan 20.
5
Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma.长链非编码 RNA HOTAIR 促进胆管癌的发生发展并预测不良预后。
Sci Rep. 2018 Aug 15;8(1):12176. doi: 10.1038/s41598-018-29737-4.
6
Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.上调的LINC00261预示着胆管癌预后不良,并通过上皮-间质转化过程促进转移。
Pathol Res Pract. 2020 Jan;216(1):152733. doi: 10.1016/j.prp.2019.152733. Epub 2019 Nov 11.
7
The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.SOCS3和A20在人类胆管癌中的预后作用
PLoS One. 2015 Oct 20;10(10):e0141165. doi: 10.1371/journal.pone.0141165. eCollection 2015.
8
Expression and clinical significance of interleukin-6 pathway in cholangiocarcinoma.胆管癌中白细胞介素-6 通路的表达及临床意义。
Front Immunol. 2024 May 31;15:1374967. doi: 10.3389/fimmu.2024.1374967. eCollection 2024.
9
YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma.YKL-40/几丁质酶-3样蛋白1与胆管癌预后不良相关,并促进胆管癌细胞的生长和迁移。
Tumour Biol. 2016 Jul;37(7):9451-63. doi: 10.1007/s13277-016-4838-z. Epub 2016 Jan 19.
10
Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.LASP-1表达上调与人类胆管癌的恶性表型及其潜在治疗作用相关。
Tumour Biol. 2016 Jun;37(6):8305-15. doi: 10.1007/s13277-015-4704-4. Epub 2016 Jan 4.

引用本文的文献

1
CK2B is a Prognostic Biomarker and a Potential Drug Target for Hepatocellular Carcinoma.CK2B是肝细胞癌的一种预后生物标志物和潜在药物靶点。
Recent Pat Anticancer Drug Discov. 2024;19(5):622-634. doi: 10.2174/0115748928262221230925090120.
2
Subcellular localization of X-linked inhibitor of apoptosis protein (XIAP) in cancer: Does that matter?癌症中X连锁凋亡抑制蛋白(XIAP)的亚细胞定位:这重要吗?
BBA Adv. 2022 Mar 20;2:100050. doi: 10.1016/j.bbadva.2022.100050. eCollection 2022.
3
Anti-Growth, Anti-Angiogenic, and Pro-Apoptotic Effects by CX-4945, an Inhibitor of Casein Kinase 2, on HuCCT-1 Human Cholangiocarcinoma Cells via Control of Caspase-9/3, DR-4, STAT-3/STAT-5, Mcl-1, eIF-2α, and HIF-1α.

本文引用的文献

1
Apigenin inhibits proliferation and induces apoptosis in human multiple myeloma cells through targeting the trinity of CK2, Cdc37 and Hsp90.芹菜素通过靶向 CK2、Cdc37 和 Hsp90 的三聚体抑制人多发性骨髓瘤细胞的增殖并诱导其凋亡。
Mol Cancer. 2011 Aug 29;10:104. doi: 10.1186/1476-4598-10-104.
2
Down-regulated expression of HSP70 in correlation with clinicopathology of cholangiocarcinoma.HSP70 的表达下调与胆管癌的临床病理相关。
Pathol Oncol Res. 2012 Apr;18(2):227-37. doi: 10.1007/s12253-011-9432-5. Epub 2011 Jul 13.
3
Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma.
通过抑制酪蛋白激酶 2(Casein Kinase 2,CK2)对 HuCCT-1 人胆管癌细胞的生长、血管生成和促凋亡作用,以及对胱冬肽酶-9/3(Caspase-9/3)、死亡受体-4(DR-4)、信号转导和转录激活因子-3/5(STAT-3/STAT-5)、凋亡蛋白抑制因子-1(Mcl-1)、真核翻译起始因子-2α(eIF-2α)和缺氧诱导因子-1α(HIF-1α)的调控。
Int J Mol Sci. 2022 Jun 6;23(11):6353. doi: 10.3390/ijms23116353.
4
Inhibiting CK2 among Promising Therapeutic Strategies for Gliomas and Several Other Neoplasms.抑制CK2是胶质瘤和其他几种肿瘤有前景的治疗策略之一。
Pharmaceutics. 2022 Jan 30;14(2):331. doi: 10.3390/pharmaceutics14020331.
5
CSNK2 in cancer: pathophysiology and translational applications.CSNK2 在癌症中的作用:病理生理学及转化应用
Br J Cancer. 2022 Apr;126(7):994-1003. doi: 10.1038/s41416-021-01616-2. Epub 2021 Nov 12.
6
Protein kinase CK2: a potential therapeutic target for diverse human diseases.蛋白激酶 CK2:一种针对多种人类疾病的潜在治疗靶点。
Signal Transduct Target Ther. 2021 May 17;6(1):183. doi: 10.1038/s41392-021-00567-7.
7
Knockdown of CSNK2ß suppresses MDA-MB231 cell growth, induces apoptosis, inhibits migration and invasion.抑制酪蛋白激酶2β可抑制MDA-MB231细胞生长,诱导细胞凋亡,抑制细胞迁移和侵袭。
EXCLI J. 2020 Sep 7;19:1211-1226. doi: 10.17179/excli2020-2363. eCollection 2020.
8
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells.蛋白激酶CK2促成胆管癌细胞的恶性表型。
Oncogenesis. 2019 Oct 22;8(11):61. doi: 10.1038/s41389-019-0171-x.
9
Prognostic Value of XIAP Level in Patients with Various Cancers: A Systematic Review and Meta-Analysis.XIAP水平在各类癌症患者中的预后价值:一项系统评价与Meta分析
J Cancer. 2019 Feb 26;10(6):1528-1537. doi: 10.7150/jca.28229. eCollection 2019.
10
Protein Kinase CK2, a Potential Therapeutic Target in Carcinoma Management.蛋白激酶CK2,癌症治疗中的一个潜在治疗靶点。
Asian Pac J Cancer Prev. 2019 Jan 25;20(1):23-32. doi: 10.31557/APJCP.2019.20.1.23.
p53 和 β-catenin 突变与 CK19 表达在肝癌早期复发和预后中的作用。
J Gastrointest Surg. 2011 Feb;15(2):321-9. doi: 10.1007/s11605-010-1373-x.
4
Expression and clinical significance of hepatoma-derived growth factor as a prognostic factor in human hilar cholangiocarcinoma.肝癌衍生生长因子作为人肝门部胆管癌预后因素的表达及临床意义。
Ann Surg Oncol. 2011 Mar;18(3):872-9. doi: 10.1245/s10434-010-1303-x. Epub 2010 Sep 17.
5
Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients.CD151 过表达可作为肝内胆管癌患者的不良预后标志物。
Cancer. 2010 Dec 1;116(23):5440-51. doi: 10.1002/cncr.25485. Epub 2010 Aug 16.
6
Overexpression of nuclear protein kinase CK2 Beta subunit and prognosis in human gastric carcinoma.核蛋白激酶 CK2β亚单位在人胃癌中的过表达及其预后意义。
Ann Surg Oncol. 2010 Jun;17(6):1695-702. doi: 10.1245/s10434-010-0911-9. Epub 2010 Jan 20.
7
Impact of protein kinase CK2 on inhibitor of apoptosis proteins in prostate cancer cells.蛋白激酶CK2对前列腺癌细胞中凋亡抑制蛋白的影响。
Mol Cell Biochem. 2008 Sep;316(1-2):91-7. doi: 10.1007/s11010-008-9810-9. Epub 2008 Jun 24.
8
Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.胆管癌:发病机制、诊断和治疗的进展
Hepatology. 2008 Jul;48(1):308-21. doi: 10.1002/hep.22310.
9
Protein kinase CK2--a key suppressor of apoptosis.蛋白激酶CK2——细胞凋亡的关键抑制因子。
Adv Enzyme Regul. 2008;48:179-87. doi: 10.1016/j.advenzreg.2008.04.002. Epub 2008 Apr 30.
10
Gallstones and the risk of biliary tract cancer: a population-based study in China.胆结石与胆道癌风险:一项基于中国人群的研究
Br J Cancer. 2007 Dec 3;97(11):1577-82. doi: 10.1038/sj.bjc.6604047. Epub 2007 Nov 13.